From cybsecurity to remote inspections, recalls and quality management, medical technology regulations are rapidly expanding. This increase in global regulatory demands has presented new challenges for regulatory affairs and intelligence teams. On May 16-17, The MedTech Regulatory Intelligence Summit will bring together regulatory professionals, device developers and regulators to look at current trends in device and software regulation, as well as key pain points in achieving regulatory compliance throughout the product lifecycle.

Sessions are focused on informing and generating discussion among stakeholders, and include:

Preparing for Global Alignment in Quality Management System Regulation: An overview of FDA activities, projected timeline and insight into how you can begin to prepare for implementation of ISO 13485

Keisha Thomas

Keisha Thomas is the Associate Director for Compliance & Quality, Office of Product Evaluation & Quality, Center for Devices & Radiological Health, FDA

The Case for Quality and Its Role in Premarket Approval

Bleta Vuniqi

Bleta Vuniqi is the Lead CSO, Case for Quality Team, Center for Devices & Radiological Health, FDA. She has been with the FDA since 2010. Previously, Vuniqi was the Quality System Specialist within DMQ/OC, and Senior Program Expert in OPEQ/ORP/D1 focusing on PMA policy and process improvement. Before joining CDRH, she was an FDA investigator in ORA responsible for conducting medical device inspections and investigations.

In person and virtual registration options available

Unique Device Identifiers: Meeting Regulatory Requirements Throughout the Product Lifecycle

Indira Konduri

Indira Konduri is the Deputy Director, Division of Surveillance Support (DSS), Office of Regulatory Programs (ORP), Office of Product Evaluation & Quality, CDRH, FDA

Regulatory Advocacy: Working with Industry Associations and Your Internal Team to Influence the Regulatory Environment

Lindsay Cobbs, U.S. Policy Head, BeiGene

Lindsay Cobbs, U.S. Policy Head at BeiGene, began his career as a staff pharmacist at The Johns Hopkins Hospital in Baltimore, before joining the FDA as special assistant and lead project manager in the Office of Compliance and later as associate director in the Office of Translational Research. Prior to joining BeiGene, he served as policy lead in the Global Regulatory and Policy Intelligence Division at Janssen Pharmaceuticals, a division of Johnson & Johnson and head of Americas, Global Regulatory Policy and Intelligence for UCB.

Recall Patterns: Enforcement Trends and What CDRH is Looking at Today

Paterson Shafer, Managing Director, FTI Consulting

Paterson Shafer has more than 30 years of experience solving complex global challenges and helping clients achieve their strategic and operational objectives in the areas of regulatory affairs and operations, quality, compliance, clinical operations, safety and surveillance, manufacturing, supply chain, medical affairs and commercial compliance. His domestic and international regulatory experience includes developing new product regulatory strategies, health authority interactions, submissions/approvals, labeling compliance, 483/Warning Letter/Consent Decree response and remediation program development and execution. Shafer is a strategic advisor to the FDA and has been co-leading collaboration efforts among the FDA, the Medical Device Innovation Consortium (MDIC), and the medical device industry as part of the FDA’s Case for Quality.

View the full agenda

Are You Inspection Ready? How to Create an Inspection-Ready Team and Respond to Remote Assessment Requests

Steve Silverman, President, The Silverman Group

Steve Silverman is the President of The Silverman Group, a consultancy that serves medical product companies on regulatory, strategy, and policy issues. His professional experience includes nearly two decades in federal service working at FDA, the U.S. Department of Justice, and the Federal Trade Commission. At the FDA CDRH Office of Compliance, Silverman led device-quality initiatives, engaged Congress and the press, and guided the office’s reorganization. He also served as Vice President, Technology and Regulatory Affairs at AdvaMed.

Securing Device Software: How To Meet Shifting Regulatory Guidances for Medical Device Software, Cyber Factors That Enable or Hinder Regulatory Success, and the Current Landscape of Postmarket Surveillance, Connectivity, And Encryption

Moderator: Shannon Lantzy, Ph.D., Vice President of Consulting, MedCrypt

Naomi Schwartz, Senior Director, Cybersecurity Quality & Safety, MedCrypt

Rina Bhagat, Senior Director of Quality & Regulatory, Synchron

Kyle Erickson, Senior Director Product Security, Medtronic

Learn more and register here.

Thank you to our premium sponsor: